interferon beta (ifn-β (Synairgen)
90
Structured Review
Synairgen
interferon beta (ifn-β
Interferon Beta (Ifn β, supplied by Synairgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optimal+fitting+model+beta+function/interferon+beta/pmc07693150-409-9-1
Average 90 stars, based on 1 article reviews
Interferon Beta (Ifn β, supplied by Synairgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optimal+fitting+model+beta+function/interferon+beta/pmc07693150-409-9-1
Average 90 stars, based on 1 article reviews
interferon beta (ifn-β - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Acute Pericarditis as the Primary Presentation of COVID-19 Infection followed by Guillain-Barre Syndrome in a Healthy Young Man: A Case Report Article Snippet: Other treatments included: Article Title: Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications , Article Snippet: Interferon beta , Nebulization , Phase 2 (NCT01126177); Article Title: Progress and pitfalls of a year of drug repurposing screens against COVID-19 Article Snippet: Article Title: Triple Jeopardy in Ageing: COVID-19, Co-morbidities and Inflamm-ageing Article Snippet: Two trials have reported., in a meta-analysis, demonstrated reduced length of hospitalisation with inhaled or Article Title: Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management Article Snippet: Article Title: Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights. Article Snippet: To cite this article: Ankit Jain, Shiv Kumar Prajapati, Madhavi Tripathi, Ashok M. Raichur & Jagat R. Kanwar (2021): Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights, Expert Review of Clinical Pharmacology, DOI: 10.1080/17512433.2021.1909473 To link to this article: https://doi.org/10.1080/17512433.2021.1909473 Vaccines:Article Title: Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses. Article Snippet: The goals of coronavirus disease 2019 (COVID-19) antiviral therapy early in the pandemic were to prevent severe disease, hospitalization, and death.. As these outcomes have become infrequent in the age of widespread population immunity, the objectives have shifted.. For the general population, COVID-19–directed antiviral therapy should decrease symptom severity and duration and minimize infectiousness, and for immunocompromised individuals, antiviral therapy should reduce severe outcomes and persistent infection. |